BIOMAT Database Logo BIOMAT Database Logo

[Delayed results of treatment of pulmonary tuberculosis with rifampicin]. 1974

P Fréour, and M Bernadou, and P Chomy

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Fréour, and M Bernadou, and P Chomy
[Preliminary results of treatment of pulmonary tuberculosis with rifampicin].
January 1969, Giornale italiano delle malattie del torace,
P Fréour, and M Bernadou, and P Chomy
[Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
July 1973, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
P Fréour, and M Bernadou, and P Chomy
[Treatment of pulmonary tuberculosis with rifampicin].
March 1969, Revue de tuberculose et de pneumologie,
P Fréour, and M Bernadou, and P Chomy
[Treatment of pulmonary tuberculosis with rifampicin].
January 1969, Giornale italiano delle malattie del torace,
P Fréour, and M Bernadou, and P Chomy
[Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
January 1972, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
P Fréour, and M Bernadou, and P Chomy
[Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
P Fréour, and M Bernadou, and P Chomy
[Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
April 1971, Revista brasileira de medicina,
P Fréour, and M Bernadou, and P Chomy
[Rifampicin in the treatment of pulmonary tuberculosis].
January 1969, Annali dell'Istituto "Carlo Forlanini",
P Fréour, and M Bernadou, and P Chomy
Rifampicin in the treatment of pulmonary tuberculosis.
June 1970, Bulletin of the International Union against Tuberculosis,
P Fréour, and M Bernadou, and P Chomy
[Rifampicin in the treatment of pulmonary tuberculosis].
January 1971, Ftiziologia,
Copied contents to your clipboard!